Perspective Therapeutics Inc (CATX)

SG&A Expense Growth

11.60%

Quarterly · Period ending:

CATX logo

CATX SG&A Expense Growth

Latest reported11.60%
CATX Quarterly SG&A Growth (QoQ) (0.00% → 11.60%)
High-resolution chart · PNG

CATX sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Perspective Therapeutics Inc SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
-52.5316%
110.6667%
3,962.5%
-4%
4.1667%
-99.8091%
1,622.3288%
57.6674%
-82.7881%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.